Hummelstown, PA, United States of America

Karam El-Bayoumy

This inventor holds 1 USPTO granted patent. Top assignee: The Penn State Research Foundation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karam El-Bayoumy. Retrieved from https://idiyas.com/inventor/karam-el-bayoumy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karam El-Bayoumy: Innovator in Liposomal Compositions

Introduction

Karam El-Bayoumy is a notable inventor based in Hummelstown, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of liposomal compositions. His innovative work focuses on enhancing the stability and delivery of bioactive agents.

Latest Patents

Karam El-Bayoumy holds a patent for "Acid stable liposomal compositions and methods for producing the same." This invention relates to a liposomal formulation designed for the oral delivery of bioactive agents, emphasizing pH stability and oxidative stability. The lipid formulations developed by El-Bayoumy are superior to conventional liposomes, as they provide enhanced stability and eliminate the need for intravenous delivery of bioactive agents. One notable application of his invention is the oral delivery of insulin or its prodrugs.

Career Highlights

Karam El-Bayoumy is associated with the Penn State Research Foundation, where he continues to advance research in liposomal technology. His work has the potential to revolutionize the way bioactive agents are delivered, making treatments more accessible and effective.

Collaborations

He has collaborated with esteemed colleagues such as Mark Kester and Christine Skibinski, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Karam El-Bayoumy's contributions to liposomal compositions represent a significant advancement in pharmaceutical science. His innovative approach to oral delivery systems has the potential to improve patient outcomes and transform treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…